Net Asset Value • Apr 1, 2015
Net Asset Value
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information
RNS Number : 2232J
Hutchison China Meditech Limited
01 April 2015
Hutchison China MediTech Limited ("Chi-Med")
(AIM: HCM)
Directors' Shareholding
London: Wednesday, 1 April 2015: Chi-Med received notifications on 1 April 2015 that the following Directors have purchased ordinary shares of US$1.00 each in Chi-Med (the "Shares") as follows:-
| Director | Date of purchase | Number of Shares purchased | Purchase price | Beneficial interest in Shares following purchases | |
| Number of Shares | % of total issued share capital | ||||
| Simon To (Executive Director and Chairman) | 30 March 2015 1 April 2015 |
13,000 15,000 |
GBP13.00 GBP13.65 |
69,000 | 0.13% |
| Edith Shih (Non-executive Director and Company Secretary) | 30 March 2015 1 April 2015 |
13,000 15,000 |
GBP13.00 GBP13.65 |
48,000 | 0.09% |
Ends
Enquiries
| Chi-Med | Telephone: +852 2121 8200 |
| Christian Hogg, CEO | |
| Panmure Gordon (UK) Limited | Telephone: +44 20 7886 2500 |
| Richard Gray | |
| Andrew Potts | |
| Citigate Dewe Rogerson | Telephone: +44 20 7638 9571 |
| Anthony Carlisle | Mobile: +44 7973 611 888 |
| David Dible | Mobile: +44 7967 566 919 |
About Chi-Med
Chi-Med is a China-based healthcare group focused on researching, developing, manufacturing and selling pharmaceuticals and health-related consumer products. Its Drug R&D Division focuses on discovering and developing innovative therapeutics in oncology and autoimmune diseases. Its China Healthcare Division manufactures, markets and distributes prescription and over-the-counter pharmaceuticals in China. Its emerging Consumer Products Division focuses on organic and natural consumer products in Asia.
Chi-Med is majority owned by the multinational conglomerate Hutchison Whampoa Limited (SEHK:13). For more information, please visit: www.chi-med.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSPKDDQQBKDQQK
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.